Serina Therapeutics CSO sells $19,680 in shares
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Serina Therapeutics Inc (SER)
Serina Therapeutics Inc stock price live, this page displays NYSE SER stock exchange data. View the SER premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Serina Therapeutics Inc real time stock price chart below.
What Is the Serina Therapeutics Inc Stock Price Today?
The Serina Therapeutics Inc stock price today is 2.3700.
What Is the Stock Symbol for Serina Therapeutics Inc?
The stock symbol for Serina Therapeutics Inc is "SER."
What Stock Exchange Does Serina Therapeutics Inc Trade On?
Serina Therapeutics Inc is listed and trades on the NYSE stock exchange.
Is Serina Therapeutics Inc a Good Stock to Buy?
Determining whether Serina Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SER quote. (ISIN: US81751A1088)
What Is the Serina Therapeutics Inc Stock Price Today?
The Serina Therapeutics Inc stock price today is 2.3700.
What Is the Stock Symbol for Serina Therapeutics Inc?
The stock symbol for Serina Therapeutics Inc is "SER."
What Stock Exchange Does Serina Therapeutics Inc Trade On?
Serina Therapeutics Inc is listed and trades on the NYSE stock exchange.
Is Serina Therapeutics Inc a Good Stock to Buy?
Determining whether Serina Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SER quote. (ISIN: US81751A1088)
NYSE
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.1100
2.4700
52 wk Range
1.7101
7.9200
SER is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.11002.4700
52 wk Range
1.71017.9200
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SER Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
13.0000
Upside
+448.52%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
- Serina Therapeutics CSO sells $23,185 in shares
- Investing.com
- Serina Therapeutics CSO sells $19,680 in shares
- Investing.com
- Serina Therapeutics CSO sells $23,185 in shares
- Investing.com
- Serina Therapeutics CSO sells $7375 in shares
- Investing.com
- Serina Therapeutics CSO sells $12,140 in shares
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Serina Therapeutics Inc Company Profile
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson’s disease that is in preclinical stage development; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214 a POZ conjugate of rotigotine for the treatment of early Parkinson’s and Restless Leg Syndrome, which has completed phase 1a clinical trial. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc. was founded in 2006 and is based in Huntsville, Alabama.
Compare SER to Peers and Sector
Metrics to compare | SER | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSERPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.4x | −1.5x | −0.5x | |
PEG Ratio | 0.03 | −0.05 | 0.00 | |
Price/Book | −8.0x | 3.6x | 2.6x | |
Price / LTM Sales | 220.4x | 112.1x | 3.3x | |
Upside (Analyst Target) | - | 204.9% | 45.8% | |
Fair Value Upside | Unlock | 18.6% | 6.4% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 13.0000
(+448.52% Upside)
Earnings
Latest Release
Nov 13, 2025
EPS / Forecast
-0.45 / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Serina Therapeutics (SER) Stock Price Today?
The Serina Therapeutics stock price today is 2.3700
What Stock Exchange Does Serina Therapeutics Trade On?
Serina Therapeutics is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Serina Therapeutics?
The stock symbol for Serina Therapeutics is "SER."
What Is the Serina Therapeutics Market Cap?
As of today, Serina Therapeutics market cap is 25.56M.
What Is Serina Therapeutics's Earnings Per Share (TTM)?
The Serina Therapeutics EPS (TTM) is -1.92.
From a Technical Analysis Perspective, Is SER a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Serina Therapeutics Stock Split?
Serina Therapeutics has split 1 times.
How Many Employees Does Serina Therapeutics Have?
Serina Therapeutics has 13 employees.
What is the current trading status of Serina Therapeutics (SER)?
As of Feb 09, 2026, Serina Therapeutics (SER) is trading at a price of 2.3700, with a previous close of 2.4700. The stock has fluctuated within a day range of 2.1100 to 2.4700, while its 52-week range spans from 1.7101 to 7.9200.
What Is Serina Therapeutics (SER) Price Target According to Analysts?
The average 12-month price target for Serina Therapeutics is USD13.0000, with a high estimate of USD15 and a low estimate of USD11. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +448.52% Upside potential.
What Is the SER Premarket Price?
SER's last pre-market stock price is 2.3800. The pre-market share volume is 8,430.0000, and the stock has decreased by -0.0900, or -3.6400%.
What Is the SER After Hours Price?
SER's last after hours stock price is 2.3748, the stock has decreased by 0.0048, or 0.2000%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.